Mutations in mitochondrial ATP synthase 6 (MT-ATP6) are a frequent cause of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) or Leigh syndromes, especially a point mutation at nucleotide position 8993. M.8969G>A is a rare MT-ATP6 mutation, previously reported only in three individuals, causing multisystem disorders with mitochondrial myopathy, lactic acidosis, and sideroblastic anemia or IgA nephropathy. We present two siblings with the m.8969G>A mutation and a novel, substantially milder phenotype with lactic acidosis, poor growth, and intellectual disability. Our findings expand the phenotypic spectrum and show that mtDNA mutations should be taken account also with milder, stable phenotypes.
Introduction
MT-ATP6 in mitochondrial DNA (mtDNA) encodes subunit 6 of the F1Fo ATP synthase (complex V) of the oxidative phosphorylation system, which synthesizes ATP using the energy provided by the mitochondrial electrochemical gradient. Mutations in MT-ATP6 gene are a frequent cause of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) or Leigh syndrome phenotypes, with the most frequent cause being a point mutation at nucleotide position m.8993 T>C or T>G [1] [2] [3] . Other clinical presentations associated with MT-ATP6 mutations include Leber's hereditary optic neuropathy (LHON) [4] , peripheral neuropathy [5] , bilateral striatal necrosis [6] , hypertrophic cardiomyopathy [7] , and the recently reported MLASA (mitochondrial myopathy, lactic acidosis, and sideroblastic anemia) [8] and IgA nephropathy plus [9] phenotypes. Age-of-onset of these diseases varies from infant to late adulthood.
Point mutations at nucleotide position m.8696 are very rare and been reported only with different multisystem phenotypes [8, 9] . Here, we report a novel, substantially milder phenotype associated with the m.8969G>A mutation.
Materials and methods
All samples were obtained for diagnostic purposes with informed consent from the parents or family members themselves. The study was approved by the institutional ethics committee. Genomic DNA was extracted from peripheral blood or muscle tissue samples by standard procedures.
Mitochondrial DNA sequencing and heteroplasmy determination
Mitochondrial DNA was sequenced as previously described [10] . We utilized next-generation sequencing (NGS) of mtDNA to quantify mtDNA heteroplasmy (skeletal muscle of the index individual, blood from the other family members). Amplification of mtDNA was performed using REPLI-g mitochondrial DNA kit and sequenced with an Illumina HiSeq2000 platform. Sequence reads were aligned to the Human mtDNA Cambridge reference sequence (NC_012920) and variants called as previously described [11] . Call depth was in all measurements above 3300×.
Blue-native polyacrylamide gel electrophoresis (BN-PAGE) and immunoblotting BN-PAGE was performed as described [12] . Native protein extracts were separated on NativePAGE Novex 4-16% BisTris acrylamide gels (Invitrogen) and transferred to PVDF membranes. Immunoblotting was performed with antibodies: CI-NDUFA9 (Abcam, #14713), CII-SDHA (Abcam, #14715), CIV-COXI (Abcam, #ab14705), and CV-ATP5A (Abcam, #ab14748).
High-resolution respirometry
High-resolution respirometry was performed as described [13] . Briefly, 2 × 10 6 digitonin-permeabilized fibroblast cells were used per sample in a substrate-uncoupler-inhibitor protocol on an Oroboros oxygraph-2k. Oxygen consumption was determined in the presence of pyruvate-glutamate malate and subsequent activities by addition of substrates +ADP (CI), +succinate (CI + CII), maximal uncoupled respiration by FCCP titration, and CIV by ascorbate +TMPD.
Results

Clinical data
We studied a family with two affected children. The index case, individual III-4, was the fourth child of nonconsanguineous parents. She was born preterm at 34 weeks of gestational age and was small for date. She received red blood cell transfusion once. Heart ultrasound revealed a patent foramen ovale. Her growth had been poor and developmental delay was noticed during the second year of life. No regression had been noticed, but her skills improved slowly. She learned to walk independently at 4.5 years of age and talked with only a few words. Psychological testing showed mild to moderate intellectual disability. At the age of 5 years her height was − 3 SD, weight − 26%, and head circumference − 3.5 SD.
Lactate was elevated in the blood and CSF. Brain MRI and proton magnetic resonance spectroscopy at 2 years of age were normal. Muscle biopsy sample showed normal histology, but respiratory chain enzyme analysis showed normal enzyme activities with decreased ATP production. Steatosis was found in the liver biopsy sample. At the age of 4 years, ophthalmological examination showed mild tortuosity of the retinal vessels, and cardiologic examination was normal.
Hearing was within normal range in audiological examination.
Her older brother (individual III-1), the first child of the family, was also born at 34 weeks of gestational age. He had mild intellectual disability and attention deficit hyperactivity disorder, was able to walk and run, was verbal with sentences, and attended special education at school. His blood lactate was normal whereas CSF lactate was elevated. His brain MRI and 1 H-MRS, cardiologic, and audiological examinations were normal. He had tortuosity of the retinal vessels; otherwise, ophthalmological findings were normal. At the age of 9 years, his height was − 1.3 SD, weight − 24%, and head circumference − 1.5 SD.
Detailed clinical data are presented in Table 1 including comparison with the previously reported subjects.
Mitochondrial ATP6 m.8969G>A mutation identified as the genetic cause Sanger sequencing of the entire mtDNA revealed an apparently homoplasmic point mutation m.8969G>A [p.Ser148Asn] in MT-ATP6 in the muscle of individual III-4. To determine the pathogenicity and accurate heteroplasmy of the mutation, we screened the muscle DNA of individual III-4, and the blood DNA from the affected brother (III-1) and five healthy family members by NGS. The affected individuals (III-4 and III-1) had high mutant load (79-95%) whereas the healthy family members had low or near zero percentages of mutant mtDNA (Fig. 1a) .
Consequences of the m.8969G>A mutation BN-PAGE revealed normal levels of assembled ATP synthase as well as complexes of the respiratory chain in fibroblasts and muscle of individual III-4 (Fig. 1b) . Long exposure revealed only a small fraction of the total ATP synthase pool not to be assembled, indicating that m. 8969G>A variant does not specifically affect ATP synthase assembly as in other ATP6 mutations [14] . Functional analysis by oxygen consumption showed decreased ADP-stimulated respiration in patient fibroblasts (Fig. 1c) . As state 3 respiration was decreased in patient cells (state 3/base ratio in patient 3.1 (control 5.0), residual oxygen consumption after uncoupling (FCCP) demonstrated that the oxidative phosphorylation capacity was limited by complex V.
Discussion
We describe here two siblings with the maternally inherited m. 8969G>A mtDNA variant and a stable phenotype with lactic acidosis, poor growth and intellectual disability. The phenotype in this family is much milder than in the previously reported cases.
The patient reported by Burrage et al. had a severe prenatalonset progressive disorder characterized by multi-organ involvement, including transfusion-dependent sideroblastic anemia, failure to thrive, sensorineural hearing impairment, epilepsy, structural brain anomaly (agenesis of corpus callosum), severe developmental delay, and stroke-like episodes. Recently, Wen et al. reported a patient also carrying the m.8969G>A mutation, with a multi-organ disorder, manifesting with IgA nephropathy at teen-age, progressing to epilepsy, muscle weakness, hearing loss, brain atrophy, and electrical abnormality of the heart (Wolff-Parkinson-White syndrome). Our subjects had stable developmental delay with poor growth and elevated lactate, no exacerbations or other organ involvements, and normal brain MRI. Interestingly, the heteroplasmy of the variant in muscle was even higher in our subject (individual III-4), 95%, compared to 88% of the 
b blood, csf cerebro-spinal fluid, f fibroblasts, 1 H-MRS proton magnetic resonance spectroscopy, IVH intraventricular hemorrhage, k kidney, m muscle, mo months, NA not available NE not evaluated, p plasma, u urine, WPW Wolf-Parkinson-White syndrome, y years individual of Burrage et al., although the phenotype of our subject was substantially milder. Another case with early death at 7.5 months of age and similar high heteroplasmy of this variant (95% in blood, fibroblasts, and muscle) was published by Sallevelt et al., but unfortunately without any additional clinical data [15] .
Both histologic examination of the muscle biopsy sample and respiratory chain enzyme activities were normal in our subject, but ATP production was reduced as a sign of defect in oxidative phosphorylation. It has been inferred that oxidative phosphorylation capacity in this specific mutant is caused by a slower ATP synthesis rate rather than less efficient coupling [9] , which we replicated by demonstrating the reduced ADP-stimulated oxygen consumption rate in the patient fibroblasts. The milder neurological phenotype of our subjects compared to controls could be explained by lower amount of mutant mtDNA in the central nervous system, or protective modifier genes in this family.
Our report expands the phenotypic spectrum caused by this rare MT-ATP6 variant. Childhood-onset mitochondrial disorders are often progressive, devastating disorders, but they should be taken into account even with milder, stable phenotypes. Fig. 1 a Pedigree with percentages of the m.8969G>A variant in the muscle of the index subject (individual III-4) and in blood of other family members, as determined by next-generation sequencing. b Bluenative PAGE and immunoblotting of respiratory chain complexes in fibroblasts and muscle from individual III-4. Total levels of ATP synthase (CV) and respiratory chain complexes were similar to control, but a subcomplex of CV was observed in individual III-4's fibroblasts only (asterisk). c Trace of oxygen consumption rates in fibroblasts from individual III-4 (pmol/s/mio cells). ADP-stimulated respiration was decreased in her fibroblasts compared to control fibroblasts, whereas uncoupled (ATPase-independent) respiration was normal
